Immunocytochemical staining revealed that all cancer-associated and ‘normal’ breast fibroblasts from six different patients were negative for CK19 compared with the positive control MDA-MB-231 breast cancer cells (Figure 1) and were positive for ASMA. The gene discussed is KRT19; the disease is breast cancer.